
Bio-Rad Laboratories BIO
$ 267.99
-0.55%
Quarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories Interest Expense 2011-2026 | BIO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.9 M | 49.4 M | 38.1 M | 1.55 M | 21.9 M | 23.4 M | 24 M | 23 M | 23.4 M | 21.7 M | 22.1 M | 61.3 M | 51.1 M | 53.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.3 M | 1.55 M | 33.1 M |
Quarterly Interest Expense Bio-Rad Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6 M | 12 M | 12.2 M | 12.3 M | 12.3 M | 12.4 M | 12.3 M | 12.3 M | - | 11.7 M | 10.7 M | 4.05 M | - | 426 K | 363 K | 398 K | - | 5.73 M | 5.74 M | 5.69 M | - | 5.52 M | 5.84 M | 5.99 M | - | 6.06 M | 5.98 M | 5.78 M | - | 5.87 M | 6.04 M | 5.32 M | - | 5.63 M | 5.63 M | 5.58 M | - | 5.82 M | 4.83 M | 5 M | - | 7.71 M | 5.56 M | 3.86 M | - | 31.6 M | 11.7 M | 11 M | - | 11.9 M | 12.4 M | 13.2 M | - | 12.3 M | 12 M | 16.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.6 M | 363 K | 8.59 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.24 | 0.9 % | $ 3.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.47 | 0.19 % | $ 1.41 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.56 | -3.75 % | $ 1.88 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.61 | -13.93 % | $ 272 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.37 | 0.12 % | $ 601 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.95 | -7.49 % | $ 836 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 71.28 | 0.11 % | $ 106 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.92 | -3.21 % | $ 146 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.71 | -1.69 % | $ 1.14 B | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 65.5 | 0.75 % | $ 1.94 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.44 | -0.05 % | $ 121 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 108.49 | -2.04 % | $ 189 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.38 | -3.7 % | $ 336 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.66 | -3.2 % | $ 391 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.07 | -4.61 % | $ 1.26 M | ||
|
AxoGen
AXGN
|
167 K | $ 30.94 | -5.53 % | $ 1.42 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 172.41 | -2.11 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 8.9 | -2.2 % | $ 685 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 34.03 | 0.86 % | $ 5.07 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.67 | -1.87 % | $ 151 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.41 | 5.24 % | $ 42.1 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 99.67 | -3.04 % | $ 1.27 B |